http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#head http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#assertion http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#assertion http://bio2rdf.org/drugbank:DB00214 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB00784 http://bio2rdf.org/drugbank:DB00784 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB00784 http://bio2rdf.org/drugbank_resource:DB00214_DB00784 http://purl.org/dc/terms/identifier drugbank_resource:DB00214_DB00784 http://bio2rdf.org/drugbank_resource:DB00214_DB00784 http://purl.org/dc/terms/title DDI between Torasemide and Mefenamic acid - Mefanamic acid, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Mefanamic acid is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00214_DB00784 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00214_DB00784 http://www.w3.org/2000/01/rdf-schema#label DDI between Torasemide and Mefenamic acid - Mefanamic acid, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Mefanamic acid is initiated, discontinued or dose changed. [drugbank_resource:DB00214_DB00784] http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#signature.MCwCFFRDsZzgtnpK http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#signature.MCwCFFRDsZzgtnpK http://purl.org/nanopub/x/hasSignature MCwCFFRDsZzgtnpKkS4Fz6t73dnD/2wNAhQMIwXyHAADQMgoS6B/uGdoWjyqcQ== http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#signature.MCwCFFRDsZzgtnpK http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://purl.org/dc/terms/created 2018-03-30T11:13:10.484+02:00 http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w#signature.MCwCFFRDsZzgtnpK http://bio2rdf.org/drugbank_resource:DB00214_DB00784_nanopub.RA3EDXCbQZ0XMijLyk-EEUdYA0vf0BTlMPerfWutvyp8w http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234